Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pharming Group N.V (PHAR) Return on Capital Employed: 2021-2025

Historic Return on Capital Employed for Pharming Group N.V (PHAR) over the last 4 years, with Sep 2025 value amounting to 0.28%.

  • Pharming Group N.V's Return on Capital Employed rose 37.00% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year increase of 37.00%. This contributed to the annual value of -0.02% for FY2024, which is 1.00% down from last year.
  • Latest data reveals that Pharming Group N.V reported Return on Capital Employed of 0.28% as of Q3 2025, which was up 2,070.09% from -0.01% recorded in Q2 2025.
  • In the past 5 years, Pharming Group N.V's Return on Capital Employed ranged from a high of 0.36% in Q2 2021 and a low of -0.09% during Q2 2024.
  • For the 3-year period, Pharming Group N.V's Return on Capital Employed averaged around -0.03%, with its median value being -0.07% (2023).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by 32bps in 2022, then surged by 37bps in 2025.
  • Over the past 5 years, Pharming Group N.V's Return on Capital Employed (Quarterly) stood at 0.04% in 2021, then grew by 8bps to 0.12% in 2022, then decreased by 17bps to -0.05% in 2023, then fell by 2bps to -0.07% in 2024, then skyrocketed by 37bps to 0.28% in 2025.
  • Its Return on Capital Employed stands at 0.28% for Q3 2025, versus -0.01% for Q2 2025 and -0.07% for Q4 2024.